Content Type: Article

  • Bulletin Concurrence XVI

    Bulletin Concurrence XVI

    ARTICLE

    Bulletin Concurrence XVI

    February 2026

    Read time: 2 min

    Key takeaways
    Overview

    We are delighted to share the sixteenth Bulletin Concurrence which aims to keep you up to date with the key developments in competition law over the last quarter of 2025.

    Read the full Bulletin Concurrence XVI (in French).

    In depth
    Authors
    More insights

  • Key takeaways from the 2026 ASTP annual meeting

    Key takeaways from the 2026 ASTP annual meeting

    ARTICLE

    Key takeaways from the 2026 ASTP annual meeting

    February 20, 2026

    Read time: 11 min

    Key takeaways
    Overview

    At a glance

    During the US Department of Health and Human Services (HHS) Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology (ASTP) annual meeting on February 11 – 12, 2026, policy makers emphasized Trump administration priorities, including:

    • Support for artificial intelligence (AI) solutions and other innovative technology.
    • Sustained government attention to information blocking, including cross-agency participation from the Federal Trade Commission (FTC), US Department of Justice (DOJ), and HHS Office of Inspector General (OIG).
    • Support for interoperability solutions leveraging Fast Healthcare Interoperability Resources (FHIR®) standards and the Trusted Exchange Framework and Common Agreement (TEFCA).
    In depth

    Upcoming regulatory developments

    • ASTP encouraged annual meeting attendees to submit comments on the Health Data, Technology, and Interoperability: ASTP/ONC Deregulatory Actions to Unleash Prosperity (HTI-5) proposed rule. The comment period remains open until February 27, 2026. For more information about the HTI-5 proposed rule, see our client alert or visit McDermott Will & Schulte’s Information Blocking and Interoperability in Healthcare resources page.
    • ASTP indicated HTI 6 is anticipated in summer 2026 and is expected to focus on facilitating interoperability with an emphasis on health applications. Tom Keane, assistant secretary for technology policy and national coordinator for health information technology, stated that stakeholders should include ideas for HTI 6 in their HTI 5 comments, even if those ideas may be viewed as “out of scope.”
    • ASTP indicated that the Centers for Medicare & Medicaid Services (CMS) plans to launch a national provider directory in March 2026, combining current HHS directories into a single primary source. ASTP also indicated that the directory will be piloted with stakeholders for accuracy and that stakeholders may be able to review and test the information. The directory is expected to include new data fields, including whether providers participate in a CMS-aligned network.
    • CMS seeks to modernize the US digital health ecosystem and is focused on providing Medicare beneficiaries with greater access to innovative technologies through its Health Tech Ecosystem initiative, a public-private collaboration between CMS and the healthcare industry. The initiative is organized by seven industry categories, including CMS-aligned networks, electronic health records (EHRs) and providers, payers, patient-facing apps, friends of the ecosystem, patients and/or caregivers, and states. Amy Gleason, acting administrator of US DOGE Service, noted that each category of the Health Tech Ecosystem is expected to announce its minimally viable product on July 4, 2026.
    • Presenters indicated that the prescription drug prior authorization proposed rule is expected in March 2026 and is currently at the Office of Management and Budget.

    Information blocking signals

    • The annual meeting included a half-day information blocking bootcamp with speakers from the FTC Technology Enforcement Division, DOJ Antitrust Division, and the HHS OIG.
    • ASTP indicated it is issuing notices of nonconformity to developers of certified health information technology (IT) under its health IT certification authorities.
    • While OIG information blocking investigations are underway, ASTP and OIG regulators did not disclose timing for OIG enforcement actions.
    • HHS, DOJ, and FTC presenters expressed concern about “dominant tech gatekeepers” using control over access to customers and their data to stifle up-and-coming competitors.
    • Similarly, regulators expressed a policy goal of supporting the next generation of health IT innovators, particularly those “realizing the revolutionary potential of AI,” and not “big companies with large compliance teams,” said former HHS deputy secretary Jim O’Neill.
    • Michael Lipinski of ASTP stated that the HTI 5 proposed rule’s changes to the “manner exception exhausted” condition of the infeasibility exception would better support “best-in-breed” solutions while not requiring bespoke interoperability elements.
    • Lipinski also noted that, consistent with the HTI-5 proposed rule’s preamble guidance, ASTP proposes to remove the TEFCA manner exception because of feedback that the exception discourages TEFCA participation.

    TEFCA: Growth, consent, and participation

    • ASTP and HHS leadership repeatedly emphasized TEFCA’s growth in participation and exchange, and described TEFCA as a “trusted interoperability backbone.”
    • HHS officials stressed the importance of participating in “two lanes,” i.e., both TEFCA and CMS-aligned networks.
    • The Social Security Administration is expected to go live with TEFCA by early spring 2026.
    • Presenters indicated that the Sequoia Project, the TEFCA recognized coordinating entity, is seeking feedback on its “Operationalizing Automated Consent” paper aimed at improving privacy and consent functionality across TEFCA. The paper is open for public comment.

    Electronic prior authorization and real-time benefits

    • Presenters highlighted the importance of real-time prescription benefit tools throughout the annual meeting.
    • As noted, HHS will likely release the prescription drug prior authorization rule in March 2026. The rule is expected to promote automation that streamlines prior authorizations and reduces administrative burden for providers, with likely compliance implications for payers and technology vendors.

    Data standards

    • Presenters discussed expanding to USCDI v7 as a further increase to the dataset standard used for interoperability, while also noting stakeholder commentary about slow movement to USCDI v3.
    • The discussion of v7 suggests that the administration may move aggressively to expand required data elements in response to complaints that earlier versions exclude data necessary for innovative technology solutions.

    Practical next steps

    • Directory readiness. Healthcare providers should consider whether their organizations should engage in provider directory testing and assign internal owners for directory data quality ahead of the March 2026 target. Accurate information on the directory could be particularly important as HHS explores changes to national provider identifier registration, which is currently done through the National Plan and Provider Enumeration System.
    • Comment strategy. If submitting comments to the HTI 5 proposed rule, consider whether to include forward-looking concepts for the anticipated HTI 6 proposed rule, consistent with Assistant Secretary Keane’s suggestion.
    • Information blocking risk mitigation. In light of the administration’s apparent commitment to information blocking enforcement and potential regulatory changes, certified EHR developers and other regulated actors should consider reassessing policies impacting access, exchange, and use of electronic health information; technical restrictions on access; and contracting/fee practices.
    • TEFCA posture. TEFCA participants (or those evaluating participation) should consider whether their exchange roadmap aligns with the emphasized “two-lane” reality of TEFCA and CMS-aligned networks. Entities already participating in TEFCA should prepare for greater transparency, including with regard to the volume of exchange occurring across the network.

    The McDermott difference

    If you have questions about how ASTP’s regulations and policy priorities would affect your organization, or if you would like assistance preparing comments to submit to ASTP, please contact any of the authors of this client alert or your regular McDermott Will & Schulte lawyer.

    Authors

    Daniel F. Gottlieb

    Partner

    Chicago

    James A. Cannatti III

    Partner

    Washington, DC

    More insights

  • Narrow carve-out from employment safe harbor: Sign-on bonuses for family-member attendants

    Narrow carve-out from employment safe harbor: Sign-on bonuses for family-member attendants

    ARTICLE / CLIENT ALERT

    Narrow carve-out from employment safe harbor: Sign-on bonuses for family-member attendants

    February 18, 2026

    Read time: 4 min

    Key takeaways
    Overview

    On December 30, 2025, the US Department of Health and Human Services Office of Inspector General (OIG) issued an unfavorable Advisory Opinion (AO) 25-12, concluding that a home care agency’s proposal to offer sign-on bonuses to prospective caregivers (Attendants), primarily targeted toward family caregivers who are in a position to select the agency on behalf of their family member who is a Medicaid beneficiary, would violate the federal Anti-Kickback Statute (AKS) and the civil monetary penalty provision prohibiting inducements to beneficiaries (known as the “Beneficiary Inducements CMP”) if the requisite intent were present.

    In depth

    Typically, the AKS employment statutory exception and regulatory safe harbor broadly protects employment compensation paid by an employer to a bona fide employee for employment in furnishing covered items and services. The 1989 proposed safe harbor rule and 1991 final safe harbor rule confirmed that employer payments to employees for generating business for the employer were protected by the safe harbor.

    However, OIG determined that “in the unique and specific circumstances” of this request, the sign-on bonus operated not as ordinary employment compensation but as “an inextricable link between the employment of the Attendant and the referral” of their family member to the home care agency prior to the start of employment, because the Attendant is also the person choosing the agency for their family member. OIG viewed the advertising of the bonus as a “solicitation for an all but guaranteed referral before employment commences.” OIG contrasted more traditional and common situations, where sign-on bonuses are offered to prospective employees with simply “the hope of future referrals but without any guarantee of referrals.” In addition to the steering risk, OIG expressed concerns that this type of bonus could create risk of unfair competition and reduced quality of care if agencies must engage in an ever-increasing bonus war, as well as risk that Attendants would select agencies based on receiving the bonus rather than on the quality of the agency.

    It is important to read this opinion in context of the “unique and specific circumstances” that OIG takes pains to point out. OIG states that where the person obtaining the bonus is the person selecting the agency for the beneficiary and the person being employed to provide the care to the beneficiary, the employment safe harbor does not cover the bonus payment. This unique and specific circumstance should not indicate risk in paying sign-on bonuses to other types of prospective employees, such as nurses or home care attendants who will not care for their own family members.

    The opinion also does not call into question the broader use of legitimate, performance based incentive compensation for employees, such as payments related to actual work performed, quality outcomes, productivity, or other job related measures, including generating business for the employer. While OIG states that a sign-on bonus is “low risk” under the AKS, OIG does not fully explaining why a sign-on bonus under normal circumstances would not be covered by the employment exception or safe harbor. The safe harbor itself protects not only payments for performing work, but also payments “for employment in the furnishing” of covered items or services. This language should be read to include any payment “for employment,” including a payment for accepting an employment offer.

    Finally, readers should also keep in mind that unfavorable opinions are only published when the requestor wants the opinion published. If OIG intends to issue an unfavorable opinion, it informs the requestor and provides an opportunity to amend or withdraw the request. Thus, the requestor wanted this opinion published, potentially to chill competitors from offering the type of sign-on bonuses described in the opinion.

    In response to the opinion. home care agencies should review their sign-on bonus programs for family-member attendants in Medicaid (and Medicaid managed care organization) consumer directed programs.

    Authors

    Tony Maida

    Partner

    New York – One Vanderbilt Avenue

    Sarah Kitchell

    Partner

    Boston

    Callee Donovan

    Associate

    Boston

    More insights

  • Pre-merger notification rule requires notice to Rhode Island AG for physician practice transactions

    Pre-merger notification rule requires notice to Rhode Island AG for physician practice transactions

    ARTICLE / CLIENT ALERT

    Pre-merger notification rule requires notice to Rhode Island AG for physician practice transactions

    Feb 18, 2026

    Read time: 6 min

    Key takeaways
    Overview

    On January 28, 2026, the Rhode Island Attorney General (AG) made effective the new Pre-Merger Notification Rule for Medical-Practice Groups. While Rhode Island has historically required pre-closing approval by both the AG and the Rhode Island Department of Health (DOH) for certain hospital transactions under the Hospital Conversion Act, the new rule requires pre-closing notification to the AG for certain transactions affecting medical-practice groups, including those involving private equity investors and management services organizations (MSOs). The AG promulgated this new rule under its regulatory and antitrust authorities. According to the AG, the increasing influence of consolidation and private equity in the healthcare sector drove the rule’s adoption. It is intended to prevent excessive market consolidation, slow healthcare cost growth, and safeguard the quality of care.

    Key takeaways

    • Written notice to the AG is required no later than 60 days prior to the effective date of any transaction involving a medical-practice group that results in a material change, including any merger, consolidation, or acquisition that would result in ownership or control by a private equity company, or the formation of an MSO or similar contracting entity responsible for administering a medical‑practice group’s contracts with health insurance carriers or third‑party administrators.
    • Failure to comply with the rule will result in monetary penalties, including a per-day fine and up to $100,000 for failing to provide notice by the transaction’s effective date.
    • The AG may also seek to enjoin a transaction until the parties have provided the 60-day pre-closing notice.
    In depth

    Analysis

    The rule creates new obligations to report transactions involving MSOs and medical-practice groups in Rhode Island, including private equity investments.

    Material change notice requirements

    Under the rule, written notice to the AG must be provided no later than 60 days before the effective date of any material change to the business or corporate structure of a medical-practice group (i.e., a physician group practice in any organizational form). The rule requires notification to the AG when:

    • A transaction involving a significant equity investor results in the change of ownership or control of a medical-practice group; or
    • An MSO or other entity is formed for the purposes of current or future contracting on behalf of one or more medical-practice groups.

    A reportable material change also occurs when a medical practice group merges; consolidates or affiliates with; sells all or substantially all of its properties, assets, or equity interests to; or has all or substantially all of its physicians employed by:

    • A hospital, hospital system, captive professional entity, medical foundation, or other entity organized or controlled by a hospital or hospital system; or
    • Another medical-practice group that results in a group of eight or more physicians, physician assistants, or nurse practitioners.

    Under the rule, “significant equity investor” targets private equity investors that have a direct or indirect “financial interest” in a medical-practice group or MSO, and any other investors that have direct or indirect ownership or possession of equity in the capital, stock, or profits totaling more than 10% of a medical-practice group or MSO.

    Notice submission for organizations undergoing a material change

    The AG published a notice of material change form on its website. Parties to a transaction must complete, sign, and submit the form via email to HCMaterialChange@riag.ri.gov no later than 60 days before the effective date of any transaction resulting in a material change. The form requires information about both parties, the nature and purpose of the proposed transaction, and any changes contemplated from the transaction, as well as a description of the anticipated impact of the proposed material change, such as any impact on reimbursement rates, care referral patterns, access to healthcare services, and quality of care. These materials are protected from disclosure to the public unless the AG determines disclosure is necessary for enforcement purposes.

    The AG is not required to respond to a submission but may contact the filer if it requires additional information. Once the filer submits the form, the filer must notify the AG of any updates to the information provided in the form within 10 business days of any such update.

    Penalties for failure to comply with notice requirements

    The rule imposes penalties of up to $200 per day for failure to provide the required 60‑day pre‑closing notice prior to the transaction’s effective date. A penalty of up to $100,000 also may be imposed if notice has not been provided by the transaction’s effective date. Depending on when notice is ultimately provided, one or both penalties may apply.

    The AG may also seek injunctive relief to delay or enjoin the finalization of any proposed transaction subject to the rule until the parties to the transaction have provided pre-closing notice of at least 60 days.

    Proposed legislation

    In parallel to the rule, Rhode Island lawmakers introduced House Bill (H.) 7172, the Health Care and Social Services Transaction Review and Significant Equity Investor Disclosure Act, on January 21, 2026. This legislation also aims to enhance disclosure for material changes 60 days prior to a transaction involving significant equity investors but differs from the rule in several ways. The proposed legislation would require additional provider types (licensed healthcare facilities and providers, as well as various types of behavioral health organizations such as residential programs and group homes) to provide notice of additional types of transactions to both the AG and DOH.

    Interested parties seeking to transact within Rhode Island’s healthcare landscape should closely monitor developments related to this pending legislation as the definition of “material change” would subject certain private equity investments in healthcare, and behavioral health in particular, to new notice requirements.

    The rule and H.7172 are part of a growing trend, and private equity investors and other parties transacting in the state should take note of increasing momentum to reshape private investment in healthcare in Rhode Island and across the United States. Visit McDermott Will & Schulte’s Health Transactions Resource Center to monitor developments.

    Authors

    Sarah Kitchell

    Partner

    Boston

    Lauren B. Flynn

    Associate

    Boston

    More insights

  • Fifth Circuit grants temporary stay preserving 2024 HSR rules

    Fifth Circuit grants temporary stay preserving 2024 HSR rules

    ARTICLE

    Fifth Circuit grants temporary stay preserving 2024 HSR rules

    Feb 20, 2026

    Read time: 2 min

    Key takeaways
    Overview

    On February 19, 2026, the US Court of Appeals for the Fifth Circuit granted the Federal Trade Commission’s (FTC) motion to temporarily stay the US District Court for the Eastern District of Texas’s order vacating the 2024 Hart-Scott-Rodino (HSR) Premerger Notification Rules “until further order” while the parties brief the FTC’s motion to stay the district court’s order pending appeal. In the order granting the temporary stay, the Fifth Circuit set an accelerated briefing schedule as to whether the stay will apply for the pendency of the appeal on the merits. The FTC filed its brief on February 18, 2026; business association plaintiffs/appellees’ response to the motion for stay pending appeal is due February 23; and the FTC’s reply is due February 26. The temporary stay keeps the 2024 rules and HSR form in effect as of now.

    We will continue to provide updates as this matter progresses.

    In depth
    Authors

    Royce E. Brosseau

    Associate

    Washington, DC

    Jon B. Dubrow

    Partner

    Washington, DC

    Noah Feldman Greene

    Partner

    Washington, DC

    Gregory E. Heltzer

    Partner

    Washington, DC

    Ryan C. Tisch

    Partner

    Washington, DC

    More insights
    Endnotes

  • New California law mandates reporting related to certain VC investments

    New California law mandates reporting related to certain VC investments

    ARTICLE / CLIENT ALERT

    New California law mandates reporting related to certain VC investments

    February 18, 2026

    Read time: 8 min

    Key takeaways
    Overview

    Update: On March 17, 2026, DFPI announced that it is suspending implementation of the FIPVCC while it continues the rulemaking and program development process. As a result, the DFPI is not presently enforcing the FIPVCC’s registration, survey, or reporting requirements, and covered entities are not required to take further compliance steps until updated guidance is issued. The DFPI has indicated that once formal rulemaking is initiated, the rulemaking process must be completed within one year. We will continue to monitor DFPI communications for further updates regarding timing and next steps.

    A new California law will require covered investment entities to register with the California Department of Financial Protection & Innovation (DFPI) by March 1, 2026, and provide demographic surveys to their portfolio companies and report any such survey responses received on an aggregated basis to the DFPI by April 1, 2026. The Fair Investment Practices by Venture Capital Companies Law (FIPVCC) was passed to increase diversity in the venture capital industry and promote more equitable investment practices. The law may, in certain cases, require registration of entities operated by firms that do not consider themselves traditional venture capital funds. Additionally, registration under the FIPVCC may be required for entities that are not based in or maintain operations in California. Investment firms and other entities making potentially covered investments should carefully review the applicability of the FIPVCC to their business.

    In depth

    Who qualifies as a covered entity?

    There are three requirements to be a covered entity to register and report under the FIPVCC.

    Is the entity a venture capital company (VCC)?

    There are three ways an entity can be considered a VCC:

    • The entity has (on at least one occasion during the annual period commencing with the date of its initial capitalization and on at least one occasion during each annual period thereafter) at least 50% of its assets comprising venture capital investments, which are defined to include investments in operating companies that come with management or certain advisory rights.
    • The entity qualifies as a venture capital fund under US Securities and Exchange Commission Rule 203(l)‑1.
    • The entity qualifies as a venture capital operating company under US Department of Labor rules.

    Does the entity primarily engage in covered activity?

    Under the FIPVCC, covered activity is the business of investing in or providing financing to “startup, early-stage, or emerging growth companies.” None of these terms is defined in the statute, nor does the FIPVCC precisely specify what constitutes being “primarily engaged in” such covered activity.[1]

    Does the entity have a California nexus?

    An entity’s California nexus can be established by the entity (i) being headquartered in the state, (ii) maintaining a significant operational footprint or office there, (iii) investing in California‑based companies, or (iv) soliciting or receiving investments from California residents.

    Registration requirements

    Beginning March 1, 2026, covered entities must register with the DFPI by submitting basic organizational and contact information. Required details include the entity’s legal name, a designated contact person with title and email address, and the firm’s principal contact information, including its email, phone number, physical address, and website. The DFPI is developing an online platform to accept these submissions and is expected to release additional guidance before the deadline. Covered entities should monitor DFPI updates so they are prepared to register promptly once the portal goes live.

    Demographic survey obligations

    Following registration, covered entities must administer a standardized demographic survey created by the DFPI. The survey must be provided to the founding team members of each portfolio company that received investment or financing from the covered entity during the prior calendar year (whether or not those portfolio companies are located in California). Please note that covered entities are required to direct the survey to the founding team members of each portfolio company, not just the portfolio company itself.[2] Information may be collected only after the covered entity has executed an investment agreement and funded the initial capital transfer. The survey requests self‑identified demographic information concerning gender identity, race, ethnicity, LGBTQ+ identification, disability status, veteran status, and California residency. These categories are more expansive than the information business entities may have been submitting in federal EEO-1 employer information reports, which require reporting only by job category, sex, and race or ethnicity.

    Participation by founding team members must be voluntary, and covered entities are required to provide a written disclosure stating that declining to respond will not result in adverse consequences and that only aggregated, anonymized information will be reported. Covered entities may also satisfy these requirements through a consolidated report submitted by a controlled entity, as long as all required information is included.

    To the extent a founding team member is also an employee of a covered entity, firms will want to ensure that they store the demographic information collected via the survey in a place separate from the individual’s personnel file.

    Annual reporting requirements

    By April 1, 2026, and annually thereafter, covered entities must submit a Venture Capital Demographic Data Report to the DFPI reflecting any information received from portfolio companies. The report must include aggregated, anonymized demographic information collected from the DFPI‑mandated surveys returned during the prior year. The report has three parts, which collect the following:

    • Part I: Aggregated information identifying the total number of survey responses received from founding team members for each demographic category identified on the report. The covered entity must still report on any founding team members, even if a founding team member declines to provide demographic information, in which case the report will reflect the individual as “decline to state” based on the DFPI’s standardized survey.
    • Part II: Information identifying, for the prior calendar year, (i) the number of investments made in companies primarily founded by diverse founding team members (in the aggregate and broken out by each demographic category), expressed as a percentage of the total number venture capital investments, and (ii) the total dollar amount of venture capital investments in businesses primarily founded by diverse founding team members (in the aggregate and broken out by each demographic category), expressed as a percentage of the total dollar amount of venture capital investments.
    • Part III: For each business that received venture capital investment from the covered entity during the prior year, a list of (i) the total amount of venture capital invested and (ii) the principal place of business. Note that the report does not require covered entities to identify each business.

    The DFPI will make all submitted reports publicly accessible, searchable, and downloadable on its website, and it may publish additional aggregated statewide results.

    If a report is not submitted by the deadline, the DFPI will issue a notice and provide the firm with a 60‑day cure period. Covered entities must also ensure that their registration information remains accurate; failure to update this information is subject to the same notice‑and‑cure procedures.

    Recordkeeping and penalties

    Covered entities must maintain records related to their obligations under the FIPVCC, including copies of all submitted reports, for at least five years after submission. Enforcement authority under the law is broad. The DFPI may issue cease‑and‑desist orders, require payment of investigative and legal costs, and impose monetary penalties. Penalties may reach $5,000 per day for ongoing violations, with larger amounts for reckless or knowing noncompliance. In determining the amount of any penalty, the commissioner and the courts may look to the following potentially mitigating factors:

    • The financial standing of the covered entity.
    • The number of assets under management by the covered entity.
    • The nature of the covered entity’s failure to comply with this chapter.
    • The amount of financial resources available to the covered entity.
    • The covered entity’s history of previous violations.

    Next steps

    It is possible that the FIPVCC could be challenged on a variety of grounds or that the registration portal will not be operational by March 1, 2026.

    For now, however, given the statute’s broad scope, investment firms with any California touchpoint should assess whether they or any affiliates fall within the FIPVCC’s definition of a covered entity. If so, they should begin developing internal processes for registration, founder outreach, survey administration, and data aggregation. When determining next steps, firms also should consider the potential applicability of privacy laws and other requirements related to sensitive personal information.

    If you have questions about whether the FIPVCC applies to your firm or need assistance preparing for compliance, please contact your regular McDermott Will & Schulte lawyer or the authors of this alert.

    Authors

    Christopher S. Avellaneda

    Partner

    New York – 919 Third Avenue

    Marc E. Elovitz

    Partner

    New York – 919 Third Avenue

    Kelly Koscuiszka

    Partner

    New York – 919 Third Avenue

    Phyllis A. Schwartz

    Partner

    New York – 919 Third Avenue

    Aroma Sharma

    Partner

    San Francisco

    More insights

  • Life sciences dealmaking accelerates in 2026: Key insights from EY’s Firepower M&A Report

    Life sciences dealmaking accelerates in 2026: Key insights from EY’s Firepower M&A Report

    ARTICLE

    Life sciences dealmaking accelerates in 2026: Key insights from EY’s Firepower M&A Report

    February 13, 2026

    Read time: 2 min

    Key takeaways
    Overview

    Life sciences companies are entering 2026 with momentum.

    According to Ernst and Young’s (EY) 2026 Firepower M&A Report, dealmaking is accelerating — driven not by short-term market shifts, but by long-term strategic fundamentals. EY was recently a Knowledge Partner at the McDermott Forum, and we are pleased to spotlight key findings from this year’s report.

    Here are several highlights:

    • M&A activity rebounded in 2025, with US$240 billion in life sciences deals signed, marking a significant increase in overall spend.
    • Average deal size rose as companies prioritized market-ready and late-stage assets positioned for near-term launch.
    • Alliance “biobucks” reached record levels, with limited upfront investment compared to total potential deal value.
    • China-based innovation reached a tipping point, capturing a growing share of inbound alliance investment.
    • A projected US$370 billion growth gap by 2032 is driving urgency among industry leaders to secure new revenue sources.
    • AI is becoming central to deal strategy, supporting sourcing, diligence, integration, and execution.
    • The industry holds approximately US$2.1 trillion in available Firepower, positioning companies to continue pursuing strategic transactions despite geopolitical and regulatory headwinds.

    The report underscores a clear message: life sciences companies depend on deals to sustain growth — and execution will matter more than ever in a competitive environment.

    Explore the full analysis and detailed data in EY’s 2026 Firepower M&A Report.

    In depth
    Authors
    More insights

  • Congress passes resolution blocking District of Columbia decoupling legislation

    Congress passes resolution blocking District of Columbia decoupling legislation

    ARTICLE

    Congress passes resolution blocking District of Columbia decoupling legislation

    Feb 13, 2026

    Read time: 2 min

    Key takeaways
    Overview

    US Congress has passed H.J.Res.142, a joint resolution to nullify legislation enacted by the District of Columbia City Council to decouple from certain One Big Beautiful Bill Act (OBBBA) provisions, including:

    • Modifications of the limit on interest that businesses may expense under Internal Revenue Code (IRC) Section 163(j).
    • The allowance of first-year expensing for new investments in qualified production property as provided for in new IRC Section 168(n).
    • Modifications to the treatment of research and experimentation expenses under IRC Section 174 and new Section 174A.

    The US Constitution provides Congress with plenary legislative authority over the District of Columbia as the federal capital, but Congress has granted limited home rule authority while “reserving the right, at any time, to exercise its constitutional authority as legislature for the district.” Generally, for noncriminal legislation, Congress has 30 business days to pass a resolution nullifying a bill passed by the District of Columbia local government. In practice, Congress has rarely exercised such authority. In fact, it is so rare that Eleanor Holmes Norton, the spokesperson for District Delegate to Congress, has claimed that there is a dispute as to whether the 30-day review period has already expired.

    Presuming the joint resolution is valid, District of Columbia officials have warned it will cost approximately $650 million over five years and could force the suspension of income tax filing deadlines to this fall because of necessary changes to tax forms, the District of Columbia’s tax processing system, and third-party tax processing software. Nevertheless, such action is consistent with the Trump administration’s public complaints about states failing to conform to the OBBBA.

    Authors

    Stephen P. Kranz

    Partner

    Washington, DC

    Michael J. Hilkin

    Partner

    New York – One Vanderbilt Avenue

    Eric D. Carstens

    Partner

    Washington, DC

    More insights
    Endnotes

  • Federal court vacates FTC’s new HSR rules

    Federal court vacates FTC’s new HSR rules

    ARTICLE

    Federal court vacates FTC’s new HSR rules

    Feb 13, 2026

    Read time: 2 min

    Key takeaways
    Overview

    On February 12, 2026, the US District Court for the Eastern District of Texas set aside and vacated the Federal Trade Commission’s (FTC) new premerger notification form and instructions. The 2024 Final Rule that amended the Premerger Notification Rules under the Hart-Scott-Rodino (HSR) Act, which became effective February 10, 2025, requires merging parties to submit substantially more documents and information to the FTC and US Department of Justice. In its decision, the court held that the new HSR rules were “arbitrary and capricious” under the Administrative Procedure Act and exceeded the FTC’s statutory authority under the HSR Act because the FTC had not shown that the additional information required was “necessary and appropriate” to determine if a proposed acquisition would violate the antitrust laws.

    The court’s order is stayed for seven days to allow the FTC time to seek emergency relief from the United States Court of Appeals for the Fifth Circuit, which could include extending the stay until resolution of the case on the merits. If the order goes into effect, the new HSR rules will be vacated, and merging parties will need to make HSR filings using the prior, simpler HSR form. This development will not affect which transactions must be reported under the HSR Act – only the level of documents and information that must be included with the initial filing.

    This is an evolving situation, so please stay tuned for continued updates and reach out to the authors with any questions.

    In depth
    Authors

    Royce E. Brosseau

    Associate

    Washington, DC

    Jon B. Dubrow

    Partner

    Washington, DC

    Noah Feldman Greene

    Partner

    Washington, DC

    Gregory E. Heltzer

    Partner

    Washington, DC

    Ryan C. Tisch

    Partner

    Washington, DC

    More insights
    Endnotes

  • IRS roundup: January 21 – February 9, 2026

    IRS roundup: January 21 – February 9, 2026

    ARTICLE

    IRS roundup: January 21 – February 9, 2026

    Feb 11, 2026

    Read time: 4 min

    Check out our summary of significant Internal Revenue Service (IRS) guidance and relevant tax matters for January 21, 2026 – February 9, 2026.

    January 26, 2026: The IRS released Notice 2026-9, which provides a one-year extension to make certain amendments to individual retirement arrangements (IRAs), simplified employee pension arrangements, and savings incentive match plan for employees IRA plans. The new deadline is December 31, 2027. The extension gives the IRS additional time to issue model language for the various changes resulting from compliance with the SECURE 2.0 Act of 2022 and related legislation.

    January 27, 2026: The IRS released Fact Sheet 2026-2, which provides updated questions and answers regarding the implementation of Executive Order 14247, Modernizing Payments To and From America’s Bank Account. The executive order advances the transition to fully electronic federal payments both to and from IRS.

    January 29, 2026: The IRS announced that it is accepting applications for the Electronic Tax Administration Advisory Committee (ETAAC) through February 28, 2026. The ETAAC provides an organized public forum for discussing electronic tax administration issues, such as prevention of identity theft and refund fraud.

    February 2, 2026: The IRS released Internal Revenue Bulletin No. 2026-6, which includes Announcement 2026-3. The announcement provides a copy of the arrangement entered into by the competent authorities of the United States and Spain regarding the implementation of the arbitration process provided for in paragraphs 5 and 6 of Article 26 of the US-Spain income tax treaty and its protocol.

    February 2, 2026: The IRS announced that it would continue operations under the current lapse in appropriations until further notice, using funding from the Inflation Reduction Act of 2022 (IRA).

    February 3, 2026: The US Department of the Treasury and the IRS issued proposed regulations regarding the clean fuel production credit enacted by the IRA and amended by the One Big Beautiful Bill Act. The new law made important changes to what is often referred to as the 45Z credit. The proposed regulations would provide rules for determining clean fuel production credits. They also would amend three sets of final regulations: the elective payment election regulations and the credit transfer election regulations (to clarify language relating to ownership of clean fuel production facilities) and the federal excise tax registration regulations (to make them clearer and more consistent with the clean fuel production credit registration requirements in these proposed regulations). The proposed regulations would affect domestic producers of clean transportation fuel, taxpayers that may claim a credit for a related producer’s fuel, and excise tax registrants. Comments must be received by April 6, 2026. There is a public hearing that will be held on May 28, 2026, and requests to speak at the public hearing will be accepted until May 26, 2026.

    Recent court decisions

    January 28, 2026: The US Tax Court issued its opinion in Aventis Inc. v. Commissioner, rejecting Aventis’s attempt to treat its cross‑border financing structure as a valid legacy financial asset securitization investment trust (FASIT). The Tax Court held that the preferred stock issued to Aventis’s French affiliate did not meet the statutory requirements for a FASIT “regular interest” and therefore functioned as equity rather than debt. Accordingly, the Tax Court found the company ineligible for the interest deductions it claimed for tax years 2008 through 2011 and upheld the IRS’s decision to reallocate the underlying asset income back to Aventis. The Tax Court also declined to find that Aventis had substantially complied with the technical rules governing FASITs prior to their statutory repeal. Although Congress repealed the FASIT regime in 2004, the Aventis structures remained subject to the pre‑repeal rules, which according to the Tax Court required strict adherence.

    The IRS also released its weekly list of written determinations (e.g., Private Letter Rulings, Technical Advice Memorandums, and Chief Counsel Advice).

    In depth
    Authors

    Suzanne Golshanara

    Associate

    Washington, DC

    Edward L. Froelich

    Counsel

    Washington, DC

    More insights
    Endnotes